The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case

The Problem of Drug Interactions Between Rosuvastatin and Ticagrelor in the Aspect of the Risk of Rhabdomyolysis: Discussion of the Problem and Description of the Clinical Case

Background. Combination therapy with two antiplatelet agents (ticagrelor or clopidogrel plus acetylsalicylic acid) and a high dose statin is recommended in accordance with clinical guidelines for patients undergoing acute coronary syndrome and coronary intervention. Combined therapeutic regimens hav...

Full description

Bibliographic Details
Main Authors: O. V. Gaisenok, Yu. M. Chichkov, M. V. Leonova
Format: Article
Language:English
Published: Столичная издательская компания 2022-11-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
rosuvastatin
ticagrelor
drug-drug interactions
side effects
rhabdomyolysis
Online Access:https://www.rpcardio.online/jour/article/view/2827

Similar Items

Similar Items